ɬÀï·¬

Publications: 1992 - 1994

To view the publications, please select the year of publication first followed by clicking on the (+) sign to access the full list of publications for that year. When you are ready to view the publications for another year, please click on the (-) sign to return to the initial default display.Ìý

Publications: 1994

Pratt S,ÌýPollak M. Insulin-like growth factor binding protein 3 (IGF-BP3) inhibits estrogen-stimulated breast cancer cell proliferation.ÌýBiochem Biophys Res CommunÌý198: 292-7, 1994.

download

Sekyi-Otu A, Bell R, Andrulis I,ÌýPollak M. Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacement.ÌýJ Natl Cancer InstÌý86: 628-32, 1994.

download

Huynh H,ÌýPollak M. Uterotrophic actions of estradiol and tamoxifen are associated with inhibition of uterine insulin-like growth factor binding protein 3 gene expression.ÌýCancer ResÌý54: 3115-9, 1994.

download

Huynh H,ÌýPollak M.ÌýEnhancement of tamoxifen-induced suppression of insulin-like growth factor I gene expression and serum level by a somatostatin analogue.ÌýBiochem Biophys Res Commun.Ìý203: 253-9, 1994.

download

Weckbecker G, Tolcsvai L, Stolz B,ÌýPollak M, Bruns C. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-Dimethylbenz (alpha) anthracene-induced rat mammary carcinomas. Cancer Res 54: 6334-7, 1994. [A footnote identifies Dr. Pollak and Dr. Bruns as co-senior authors who contributed equally to this work.]

download

Publications: 1993

Friedel A, Jordan V,ÌýPollak M.ÌýSuppression of serum insulin-like growth factor-I levels in breast cancer patients during adjuvant tamoxifen therapy.ÌýEur J CancerÌý29a: 1368-72, 1993.

download

Huynh H, Tetenes E, Wallace L,ÌýPollak M.ÌýIn vivo inhibition of insulin-like growth factor 1 gene expression by tamoxifen.ÌýCancer ResÌý53: 1727-30, 1993.

download

Pratt S, andÌýPollak MN.ÌýEstrogen and antiestrogen modulation of MCF7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media.ÌýCancer ResÌý53: 5193-8, 1993.

download

Pollack R, Pollak M, Rochon L. Pregnancy complicated by medulloblastoma with metastases to the placenta. Obstet Gynecol 81: 858-9, 1993.

Tonin P, Ehrenborg W, Lenoir G, Feunteun J, Lynch H, Morgan K, Zazzi H, Vivier A,ÌýPollak M, Huynh H, et al. The human insulin-like growth factor- binding protein 4 gene maps to chromosome region 17q12-21.1 and is close to the gene for hereditary breast-ovarian cancer.ÌýGenomicsÌý18: 414-7, 1993.

download

Huynh H,ÌýPollak M.ÌýInsulin-like growth factor I gene expression in the uterus is stimulated by tamoxifen and inhibited by the pure antiestrogen ICI 182780.ÌýCancer ResÌý53: 5585-8, 1993.

download

Publications: 1992

Malaab S,ÌýPollak MN, Goodyer CG. Direct effects of tamoxifen on growth hormone secretion by pituitary cells in vitro.ÌýEur J CancerÌý28A: 788-93, 1992.

download

Tannenbaum G, Gurd W, Lapointe M,ÌýPollak M.ÌýTamoxifen attenuates pulsatile growth hormone secretion: mediation in part by somatostatin.ÌýEndocrinologyÌý130: 3395-401, 1992.

download

Pollak M, Sem A, Richard M, Tetenes E, Bell R. Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy.ÌýJ Natl Cancer InstÌý84: 966-71, 1992.

download

Pollak MN, Huynh H, Lefebvre S. Tamoxifen reduces serum-like growth factor I (IGF-I).ÌýBreast Cancer Res TreatÌý22: 91-100, 1992.

download

Pollak M, Galant K, Poisson R, Harris A. Potential role for somatostatin analogues in breast cancer: rationale and description of an ongoing trial. MetabolismÌý41: 9 Suppl 2, 119-120, 1992.

download

Ìý

Back to top